BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10699296)

  • 1. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.
    Birnbaum DT; Kosmala JD; Henthorn DB; Brannon-Peppas L
    J Control Release; 2000 Apr; 65(3):375-87. PubMed ID: 10699296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response surface methodology to obtain beta-estradiol biodegradable microspheres for long-term therapy of osteoporosis.
    Zaghloul AA; Mustafa F; Siddiqui A; Khan M
    Pharm Dev Technol; 2006; 11(3):377-87. PubMed ID: 16895848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents.
    Wang FJ; Wang CH
    J Control Release; 2002 Jun; 81(3):263-80. PubMed ID: 12044566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of gentamicin released from microparticles.
    Blanco-Príeto MJ; Lecaroz C; Renedo MJ; Kunkova J; Gamazo C
    Int J Pharm; 2002 Aug; 242(1-2):203-6. PubMed ID: 12176247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable microparticulates of beta-estradiol: preparation and in vitro characterization.
    Zaghloul AA; Mustafa F; Siddiqu A; Khan M
    Drug Dev Ind Pharm; 2005 Sep; 31(8):803-11. PubMed ID: 16221615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Estradiol biodegradable microspheres: effect of formulation parameters on encapsulation efficiency and in vitro release.
    Zaghloul AA
    Pharmazie; 2006 Sep; 61(9):775-9. PubMed ID: 17020154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface analysis of sequential semi-solvent vapor impact (SAVI) for studying microstructural arrangements of poly(lactide-co-glycolide) microparticles.
    Garner J; Skidmore S; Hadar J; Park H; Park K; Qin B; Wang Y
    J Control Release; 2022 Oct; 350():600-612. PubMed ID: 36057396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Praziquantel-loaded PLGA nanoparticles: preparation and characterization.
    Mainardes RM; Evangelista RC
    J Microencapsul; 2005 Feb; 22(1):13-24. PubMed ID: 16019887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microparticles produced by the hydrogel template method for sustained drug delivery.
    Lu Y; Sturek M; Park K
    Int J Pharm; 2014 Jan; 461(1-2):258-69. PubMed ID: 24333903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of formulation and process parameters on the characteristics of PLGA-based microparticles with controlled drug release.
    Vysloužil J; Kejdušová M; Dvořáčkov K; Vetchý D
    Ceska Slov Farm; 2013 Jun; 62(3):120-6. PubMed ID: 23961813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin.
    Cho SW; Song SH; Choi YW
    Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method.
    Niwa T; Takeuchi H; Hino T; Kunou N; Kawashima Y
    J Pharm Sci; 1994 May; 83(5):727-32. PubMed ID: 8071830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
    Yeh MK
    J Microencapsul; 2000; 17(6):743-56. PubMed ID: 11063421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable microparticles for the controlled delivery of oligonucleotides.
    De Rosa G; Quaglia F; La Rotonda M; Besnard M; Fattal E
    Int J Pharm; 2002 Aug; 242(1-2):225-8. PubMed ID: 12176251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
    Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS
    Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
    Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
    Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers.
    Boisdron-Celle M; Menei P; Benoit JP
    J Pharm Pharmacol; 1995 Feb; 47(2):108-14. PubMed ID: 7602463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of topical cidofovir penetration using microparticles.
    Santoyo S; Ga de Jalón E; Ygartua P; Renedo MJ; Blanco-Príeto MJ
    Int J Pharm; 2002 Aug; 242(1-2):107-13. PubMed ID: 12176232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.